Supplementary Figure S2 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies | Synapse
February 22, 2024Open Access
Supplementary Figure S2 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies
Key Points
Key points are not available for this paper at this time.
Abstract
Baseline CD47 expression by flow cytometry in colorectal cancer cell lines (A) and in DLBCL cell lines (B).